AGP Executive Report
Last update: 3 hours agoSwiss Consumer & Corporate Watch: Lindt & Sprüngli says H1 2026 organic sales rose 4.3% to CHF 2.33bn, but volume/mix fell 7.5% as price hikes averaged 11.8% and Europe demand stayed soft amid geopolitics and weaker tourism. Swiss Finance & Wealth: Julius Baer reports H1 profit more than doubling, with assets under management hitting a record high, while investors look for clarity on what’s next. Swiss Business & Tech: Roche is set to showcase diagnostic automation and AI-enabled lab workflows at ADLM 2026, including its Axelio 1 sequencing platform and cobas Mass Spec for routine clinical use. Cyber & Insurance: BOXX Insurance (Zurich Insurance Group) expands Cyberboxx® Business with explicit cover for AI and deepfake-driven social engineering and security failures. Health & Innovation: Immitra Bio (Zurich) secures €2.58m to scale its in-vivo genetic medicine platform. Markets: Swiss Market settles higher after a choppy session, as investors weigh global risk sentiment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
